Authors: CHAN WY WO NC STOEV S CHENG LL MANNING M

Citation: Wy. Chan et al., DISCOVERY OF NOVEL SELECTIVE HYPOTENSIVE VASOPRESSIN PEPTIDES THAT EXHIBIT LITTLE OR NO FUNCTIONAL INTERACTIONS WITH KNOWN OXYTOCIN VASOPRESSIN RECEPTORS/, British Journal of Pharmacology, 125(4), 1998, pp. 803-811

Authors: ALA Y MORIN D MAHE E COTTE N MOUILLAC B JARD S BARBERIS C TRIBOLLET E DREIFUSS JJ SAWYER WH WO NC CHAN WY KOLODZIEJCZYK AS CHENG LL MANNING M

Citation: Y. Ala et al., PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS, European journal of pharmacology, 331(2-3), 1997, pp. 285-293

Authors: CHAN WY WO NC CHENG LL MANNING M

Citation: Wy. Chan et al., ISOSTERIC SUBSTITUTION OF ASN(5) IN ANTAGONISTS OF OXYTOCIN AND VASOPRESSIN LEADS TO HIGHLY SELECTIVE AND POTENT OXYTOCIN AND V-1A RECEPTORANTAGONISTS - NEW APPROACHES FOR THE DESIGN OF POTENTIAL TOCOLYTICS FOR PRETERM LABOR, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 999-1003

Authors: CHAN WY WO NC MANNING M

Citation: Wy. Chan et al., THE ROLE OF OXYTOCIN RECEPTORS AND VASOPRESSIN V-1A RECEPTORS IN UTERINE CONTRACTIONS IN RATS - IMPLICATIONS FOR TOCOLYTIC THERAPY WITH OXYTOCIN ANTAGONISTS, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1331-1335

Authors: MANNING M MITEVA K PANCHEVA S STOEV S WO NC CHAN WY

Citation: M. Manning et al., DESIGN AND SYNTHESIS OF HIGHLY SELECTIVE IN-VITRO AND IN-VIVO UTERINERECEPTOR ANTAGONISTS OF OXYTOCIN - COMPARISONS WITH ATOSIBAN, International journal of peptide & protein research, 46(3-4), 1995, pp. 244-252